Ana Da Silva Gomes

Weill Medical Coll Of Cornell Univ

$5,259,003

Attributed

$5,259,003

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.9M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,259,003 · 5

By mechanism

DP2$2,472,750 · 1

R01$1,238,678 · 1

R00$915,500 · 1

R21$463,375 · 1

K99$168,700 · 1

Top collaborators

No co-investigators on record.

Most similar at Weill Medical Coll Of Cornell Univ

Same institution · by research overlap

Yuhua Bao$5,650,344
Marcus Dasilva Goncalves$8,791,437
Zhongchi Li$203,850
Lukas Edward Dow$10,323,278
James H Flory$1,214,623

Others in their field

Other Emerging Leaders on “Affect”

Chanza Baytop · Westat, Inc.$271,217,917
Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
George Robert Painter · University Of Alabama At Birmingham$27,619,145
Jessica Brooke Langbaum · Banner Health$22,633,312

Research focus

AffectCancer CellNeoplasm MetastasisCellsMetabolicTumorigenesisPrimary NeoplasmGeneticMetastatic Breast CancerTherapeutic TargetMortalityMalignant NeoplasmsBreast Cancer CellPhysiologicalLeadTumor ProgressionCancer TypeNeoplastic CellNew Therapeutic TargetOperative Surgical ProceduresMetabolic PathwayPathway InteractionsGrowthComplex